Edap Tms (NASDAQ:EDAP) Rating Lowered to “Sell” at StockNews.com

Edap Tms (NASDAQ:EDAP) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Stock Performance

NASDAQ:EDAP traded down $0.09 on Monday, hitting $2.36. The company’s stock had a trading volume of 78,779 shares, compared to its average volume of 60,190. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The stock has a fifty day moving average of $2.80 and a two-hundred day moving average of $4.31. The firm has a market capitalization of $87.57 million, a P/E ratio of -3.63 and a beta of 0.38. Edap Tms has a one year low of $2.27 and a one year high of $8.50.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The company had revenue of $16.97 million for the quarter, compared to the consensus estimate of $17.16 million. Research analysts predict that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

A number of hedge funds have recently made changes to their positions in the business. Virtu Financial LLC purchased a new stake in shares of Edap Tms in the 1st quarter worth about $82,000. Commonwealth Equity Services LLC lifted its stake in shares of Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after purchasing an additional 4,000 shares during the period. Redhawk Wealth Advisors Inc. bought a new stake in Edap Tms during the 3rd quarter worth approximately $36,000. BNP Paribas Financial Markets raised its stake in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares during the period. Finally, Parkman Healthcare Partners LLC bought a new stake in Edap Tms during the 3rd quarter worth approximately $395,000. 62.74% of the stock is currently owned by institutional investors.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.